Owl Rock Capital Group was a middle-market private credit and direct lending firm founded in 2016 in New York. In May 2021, it merged with Dyal Capital Partners to form Blue Owl Capital Inc. (NYSE: OWL), a leading alternative asset manager.
Deal activity increased 120% year-over-year (11 deals in the last 12 months). Average disclosed round size is $263.9M (across 51 rounds with reported amounts).
Portfolio
51
Fund Size
—
Top Stage
Growth
Last 12 Mo
11
Team
CB
Carly Brooks Prutkin
Senior Managing Director
DA
David Aidi
Senior Managing Director
EB
Eric Brotman
Senior Managing Director
JC
Jerry Cammarata
Senior Managing Director
MC
Michael Conley
Senior Managing Director
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
57 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Ambrosia Biosciences Inc. | Series B | $100M | Mar 2026 |
 Allica Bank | Series D | $155M | Feb 2026 |
 Vestwell | Series E | $385M | Feb 2026 |
 CAIS | Series D | $170M | Jan 2026 |
| VVestwell Holdings Inc. | Growth | — | Jan 2026 |
| CCoremont | Growth | $40M | Dec 2025 |
 Crusoe | Series E | $1.4B | Oct 2025 |
 Electra | Series C | $183M | Oct 2025 |
| EElectra Therapeutics | Series C | $183M | Oct 2025 |
| NNscale Global Holdings Limited | Unknown | $433M | Oct 2025 |
| GGigabit Fiber, LLC | Unknown | — | Sep 2025 |
 MapLight Therapeutics | Series D | $372.5M | Jul 2025 |
 Juniper Square | Series D | $130M | Jun 2025 |
 Latigo Biotherapeutics | Series B | $150M | Mar 2025 |
 Windward Bio | Series A | $200M | Jan 2025 |
 Star Therapeutics | Series D | $125M | Jan 2025 |
| JJuniper Square Inc | Unknown | $130M | Jan 2025 |
 Interos | Growth | $40M | Oct 2024 |
 CloudPay | Series D | $120M | Aug 2024 |
 Lycia Therapeutics | Series C | $106.6M | May 2024 |
| Vestwell | Series D | $125M | Dec 2023 |
| PPCF Insurance Services | Growth | $500M | Feb 2023 |
| Juniper Square | Growth | $133M | Feb 2023 |
| VVestwell Holdings Inc. | Series D | — | Jan 2023 |
 Securiti | Series C | $75M | Oct 2022 |
Page 1 of 3
Top Co-Investors
Franklin Templeton8 shared
OrbiMed6 shared
Tiger Global Management, LLC6 shared
Redmile Group5 shared
Sanofi Ventures5 shared
HarbourVest Partners5 shared
Cormorant Asset Management4 shared
Whale Rock Capital Management4 shared
Accel4 shared
Ribbit Capital4 shared
Viking Global Investors3 shared
New Leaf Venture Partners3 shared
RA Capital Management3 shared
Lightspeed Venture Partners3 shared
Sands Capital3 shared
Insight Partners3 shared
Sapphire Ventures3 shared
Redpoint Ventures3 shared
Fifth Wall3 shared
Last updated: 7 September 2026